Neuroblastoma CDX Models

Explore Neuroblastoma CDX Models:

Model NameDescription
CHP-134Neuroblastoma model with MYCN amplification and ALK wild-type status; used to study high-risk, treatment-resistant neuroblastoma.
BE(2)-CMYCN-amplified neuroblastoma model with TP53 mutation; exhibits aggressive growth and is used for testing differentiation agents and chemotherapy.